Skip to main content

Uniplan Investment Counsel, Inc.

Position in RPRX — Royalty Pharma plc

CIK 1520710 MILWAUKEE, WI

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,889,191
+$632,430 QoQ
Shares Held
87,198
-1.7% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#209
of 644 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Uniplan Investment Counsel, Inc. holds $24,931,715 across 4 Biotechnology names. RPRX ranks #3 (19.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 RPRX
Royalty Pharma plc
This page
87,198 $4,889,191

All Filings in RPRX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,889,191 87,198
2026-03-31 $4,256,761 88,738
2025-12-31 $3,545,065 91,746
2025-09-30 $2,533,668 71,816
2025-06-30 $2,164,214 60,067
2025-03-31 $1,613,716 51,838
2024-12-31 $1,018,716 39,934